17,935 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Purchased by SVB Wealth LLC

SVB Wealth LLC bought a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 17,935 shares of the medical instruments supplier's stock, valued at approximately $340,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of XRAY. Pacer Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after purchasing an additional 4,473,972 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of DENTSPLY SIRONA by 206.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after purchasing an additional 1,244,326 shares in the last quarter. Invenomic Capital Management LP purchased a new stake in shares of DENTSPLY SIRONA in the 3rd quarter worth $23,724,000. National Bank of Canada FI increased its stake in shares of DENTSPLY SIRONA by 85.8% in the 3rd quarter. National Bank of Canada FI now owns 1,628,200 shares of the medical instruments supplier's stock worth $44,059,000 after purchasing an additional 751,800 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of DENTSPLY SIRONA by 50.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock worth $55,900,000 after purchasing an additional 692,100 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.06 during midday trading on Friday, hitting $16.32. 2,069,171 shares of the company traded hands, compared to its average volume of 2,593,106. The firm has a 50 day moving average of $18.54 and a 200-day moving average of $21.18. DENTSPLY SIRONA Inc. has a 52 week low of $15.47 and a 52 week high of $34.28. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of -7.88, a PEG ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.92%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the acquisition, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Mizuho assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price objective for the company. Morgan Stanley cut their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research note on Tuesday, December 17th. Robert W. Baird cut their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research note on Friday, February 28th. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Friday, February 28th. Finally, Evercore ISI reiterated an "in-line" rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Eleven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and a consensus target price of $23.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.